Cardiol Therapeutics Inc.
Climate Impact & Sustainability Data (2023, 2024)
Reporting Period: 2023
Environmental Metrics
Climate Goals & Targets
Short-term Goals:
- Initiate Phase III program for recurrent pericarditis (subject to analysis of data from Phase II study)
Supply Chain Management
Climate-Related Risks & Opportunities
Reporting Period: 2024
Environmental Metrics
Climate Goals & Targets
Short-term Goals:
- Initiate MAVERIC-2 Phase II/III trial Q4 2024
- Report ARCHER Phase II topline data early 2025
- Complete IND-enabling studies for CRD-38
- Initiate Phase I clinical program for CRD-38
Supply Chain Management
Climate-Related Risks & Opportunities
Sustainable Products & Innovation
- CardiolRx™
- CRD-38